- Home
- JBL vs ICLR Comparison
JBL vs ICLR Comparison
Compare JBL & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBL
- ICLR
- Stock Information
- Founded
- JBL 1966
- ICLR 1990
- Country
- JBL United States
- ICLR Ireland
- Employees
- JBL N/A
- ICLR N/A
- Industry
- JBL Electrical Products
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- JBL Technology
- ICLR Health Care
- Exchange
- JBL Nasdaq
- ICLR Nasdaq
- Market Cap
- JBL 16.3B
- ICLR 17.2B
- IPO Year
- JBL 1993
- ICLR 1998
- Fundamental
- Price
- JBL $167.63
- ICLR $205.07
- Analyst Decision
- JBL Buy
- ICLR Strong Buy
- Analyst Count
- JBL 7
- ICLR 12
- Target Price
- JBL $155.67
- ICLR $284.82
- AVG Volume (30 Days)
- JBL 1.5M
- ICLR 910.7K
- Earning Date
- JBL 03-14-2025
- ICLR 02-19-2025
- Dividend Yield
- JBL 0.19%
- ICLR N/A
- EPS Growth
- JBL 83.88
- ICLR 44.49
- EPS
- JBL 10.81
- ICLR 8.99
- Revenue
- JBL $27,490,000,000.00
- ICLR $8,306,823,000.00
- Revenue This Year
- JBL N/A
- ICLR $3.99
- Revenue Next Year
- JBL $5.06
- ICLR $2.19
- P/E Ratio
- JBL $15.51
- ICLR $22.04
- Revenue Growth
- JBL N/A
- ICLR 3.63
- 52 Week Low
- JBL $95.85
- ICLR $183.38
- 52 Week High
- JBL $168.80
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- JBL 84.29
- ICLR 44.37
- Support Level
- JBL $150.52
- ICLR $196.50
- Resistance Level
- JBL $156.11
- ICLR $228.29
- Average True Range (ATR)
- JBL 3.51
- ICLR 6.79
- MACD
- JBL 1.28
- ICLR -1.10
- Stochastic Oscillator
- JBL 95.59
- ICLR 26.96
About JBL Jabil Inc.
Jabil Inc is a United States-based company engaged in providing manufacturing services and solutions. It provides comprehensive electronics design, production and product management services to companies in various industries and end markets.The Company derives its revenue from providing comprehensive electronics design, production and product management services. It operates in two segments. The Electronics Manufacturing Services (EMS) segment, which is the key revenue driver, is focused on leveraging IT, supply chain design and engineering, technologies largely centered on core electronics. The Diversified Manufacturing Services (DMS) segment is focused on providing engineering solutions, with an emphasis on material sciences, technologies, and healthcare.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.